Publikation: Testing the Impact of Protease Inhibitors in Antigen Presentation Assays
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
The major histocompatibility complex (MHC) class I restricted pathway of antigen processing allows the presentation of intracellular antigens to cytotoxic T lymphocytes. The proteasome is the main protease in the cytoplasm and the nucleus, which is responsible for the generation of most peptide ligands of MHC-I molecules. Peptides produced by the proteasome can be further trimmed or destroyed by numerous cytosolic or endoplasmic reticulum (ER) luminal proteases. Small molecule inhibitors are useful tools for probing the role of proteases in MHC class I antigen processing. Here, we describe different methods to test the impact of protease inhibitors in antigen presentation assays.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
BASLER, Michael, Marcus GRÖTTRUP, 2019. Testing the Impact of Protease Inhibitors in Antigen Presentation Assays. In: ENDERT, Peter van, ed.. Antigen Processing : Methods and Protocols. second edition. New York, NY: Humana Press, 2019, pp. 59-69. Methods in Molecular Biology. 1988. ISBN 978-1-4939-9449-6. Available under: doi: 10.1007/978-1-4939-9450-2_5BibTex
@incollection{Basler2019Testi-45967, year={2019}, doi={10.1007/978-1-4939-9450-2_5}, title={Testing the Impact of Protease Inhibitors in Antigen Presentation Assays}, edition={second edition}, number={1988}, isbn={978-1-4939-9449-6}, publisher={Humana Press}, address={New York, NY}, series={Methods in Molecular Biology}, booktitle={Antigen Processing : Methods and Protocols}, pages={59--69}, editor={Endert, Peter van}, author={Basler, Michael and Gröttrup, Marcus} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/45967"> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-11T09:33:36Z</dcterms:available> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-11T09:33:36Z</dc:date> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:abstract xml:lang="eng">The major histocompatibility complex (MHC) class I restricted pathway of antigen processing allows the presentation of intracellular antigens to cytotoxic T lymphocytes. The proteasome is the main protease in the cytoplasm and the nucleus, which is responsible for the generation of most peptide ligands of MHC-I molecules. Peptides produced by the proteasome can be further trimmed or destroyed by numerous cytosolic or endoplasmic reticulum (ER) luminal proteases. Small molecule inhibitors are useful tools for probing the role of proteases in MHC class I antigen processing. Here, we describe different methods to test the impact of protease inhibitors in antigen presentation assays.</dcterms:abstract> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/45967"/> <dc:language>eng</dc:language> <dc:contributor>Gröttrup, Marcus</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:title>Testing the Impact of Protease Inhibitors in Antigen Presentation Assays</dcterms:title> <dc:creator>Gröttrup, Marcus</dc:creator> <dcterms:issued>2019</dcterms:issued> <dc:creator>Basler, Michael</dc:creator> <dc:contributor>Basler, Michael</dc:contributor> </rdf:Description> </rdf:RDF>